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Abstract
Serotonin exerts a powerful influence on neuronal excitability. In this study, we investigated the effects of serotonin on
different neuronal populations in prefrontal cortex (PFC), a major area controlling emotion and cognition. Using whole-cell
recordings in PFC slices, we found that bath application of 5-HT dose-dependently increased the firing of FS (fast spiking)
interneurons, and decreased the firing of pyramidal neurons. The enhancing effect of 5-HT in FS interneurons was mediated
by 5-HT2 receptors, while the reducing effect of 5-HT in pyramidal neurons was mediated by 5-HT1 receptors. Fluoxetine, the
selective serotonin reuptake inhibitor, also induced a concentration-dependent increase in the excitability of FS
interneurons, but had little effect on pyramidal neurons. In rats with chronic fluoxetine treatment, the excitability of FS
interneurons was significantly increased, while pyramidal neurons remained unchanged. Fluoxetine injection largely
occluded the enhancing effect of 5-HT in FS interneurons, but did not alter the reducing effect of 5-HT in pyramidal
neurons. These data suggest that the excitability of PFC interneurons and pyramidal neurons is regulated by exogenous 5-
HT in an opposing manner, and FS interneurons are the major target of Fluoxetine. It provides a framework for
understanding the action of 5-HT and antidepressants in altering PFC network activity.
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Introduction
The prefrontal cortex (PFC) is a central brain region controlling
high-level executive functions and goal-directed behaviors [1].
Clinical, neuropsychological, and imaging studies have indicated
that several neuropsychiatric disorders, including depression, anxiety
and schizophrenia, are related to the deficits in cognitive and
emotional processes subserved by PFC [2–5]. PFC receives a dense
serotonergic innervation from the dorsal and median raphe nuclei
[6]. Growing evidence suggests that the serotonergic system plays an
important role in regulating prefrontal functions [7–11]. The
serotonin system is also heavily involved in depressive disorders
[12–14], and fluoxetine, which enhances serotonin levels by blocking
its reuptake, has been the most successful antidepressant drug [15].
The cellular mechanism underlying the actions of 5-HT and
fluoxetine in PFC has been largely unknown. PFC activity is
control by the excitability of two major neuronal populations:
glutamatergic excitatory pyramidal neurons and GABAergic
inhibitory interneurons [16]. The parvalbumin-expressing fast-
spiking (FS) interneuron network generates gamma oscillations
[17,18], which is critical for cognitive tasks such as attention and
sensory processing [19,20]. Specific deficits in PFC FS interneu-
rons have been found in schizophrenia patients [21]. Moreover,
alterations of prefrontal cortical activity are considered as an
important causal factor for major depression [22], which provides
a basis for the treatment of depression with brain stimulation [23].
Both PFCprincipalneuronsand interneuronscontainmultiple5-
HT receptors, with a particular abundance of the 5-HT1A and 5-
HT2A subtypes [24–26]. Blockade of PFC 5-HT2A receptors has
been found to impair working memory, which involves actions at
both excitatory and inhibitory elements within PFC circuitry [27].
Despite the findings on the effect of 5-HT on glutamatergic and
GABAergic synaptic responses in PFC pyramidal neurons [28–32],
it remains unclear about the impact of 5-HT or fluoxetine on the
intrinsic excitability of PFC interneurons and pyramid neurons.
In this study, we have found that 5-HT produces opposing
effects on the action potential firing of PFC FS interneurons and
pyramidal neurons. Fluoxetine treatment in vitro (acute) or in vivo
(chronic) mainly alters the intrinsic excitability of FS interneurons,
but not pyramidal neurons. These results provide a framework for
understanding the action of 5-HT and antidepressants in altering
PFC network activity.
Results
The effect of serotonin on the excitability of FS
interneurons and pyramidal neurons in PFC
To understand the effect of serotonin on the excitability of
cortical neuronal populations, we conducted whole-cell current-
clamp recordings to examine the action potential (AP) firing in FS
interneurons and pyramidal neurons located at layer 3–5 of PFC
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e16970from young adult rats. Pyramidal neurons were identified by their
triangular soma and a clear apical dendrite, whereas interneurons
were characterized by a round or oval cell body and the lack of a
visible apical dendrite under infrared video microscopy. Action
potentials were elicited by injecting a depolarizing current pulse.
FS interneurons generated trains of spikes of short durations (base
duration: ,2 ms) followed by a strong fast afterhyperpolarization
(fAHP) and were characterized by their fast spikes discharged at
high frequencies with little frequency adaptation (Fig. 1A) [33,34].
In contrast, pyramidal neurons fired long-duration (base duration:
,4.5 ms) and low frequency spikes that showed adaptation
followed by a weak fAHP (Fig. 1A).
Bath application of 5-HT (20 mM) significantly increased the firing
rate in FS interneurons, while decreased the firing rate in pyramidal
neurons (Fig. 1A). Both the enhancing and the reducing effects were
concentration-dependent (Fig. 1B, interneurons: 1 mM, 16.263.9%,
2 mM, 37.467.6%, 5 mM, 50.8611.3%, 20 mM, 87.6611.7%,
40 mM, 94.5610.6%, n=5–10 for each dose; pyramidal neurons:
1 mM, 25.762.1%, 2 mM, 235.263.6%, 5 mM, 248.664.8%,
20 mM,256.867.9%, 40 mM, 259.968.7%, n=5–7 for each dose).
To check whether synaptic activity influences the effect of 5-HT on
APs, we used the AMPAR antagonist CNQX (20 mM), NMDAR
antagonist APV (50 mM) and GABAAR antagonist bicuculline
(10 mM) to block excitatory and inhibitory neurotransmission. 5-
HT (20 mM) caused a similar enhancement of the firing rate in FS
interneurons in the presence of these antagonists (84.7613.3%,
n=4), suggesting that 5-HT may change the neuronal excitability by
altering their intrinsic properties.
Different 5-HT receptors mediate the distinct effects of 5-
HT in FS interneurons and pyramidal neurons
Serotonin can have both inhibitory and excitatory functions in
neuronal networks through the activation of different 5-HT receptors
[35]. We next examined which 5-HT receptors mediate the effects of
5-HT on APs in FS interneurons or pyramidal neurons. As shown in
Fig. 2A and 2B, in FS interneurons, the specific 5-HT2 antagonist
Ketanserin (10 mM) turned the enhancing effect of 5-HT to a small
reduction (213.365.7%, n=5), and Ketanserin itself had little effect
on APs. On the other hand, in pyramidal neurons (Fig. 2C and 2D),
the specific 5-HT1 antagonist NAN190 (10 mM) turned the reducing
effect of 5-HT to a small enhancement (32.867.6%, n=7), and
NAN190 itself did not alter APs. Blocking both 5-HT1 and 5-HT2
receptors with Ketanserin and NAN190 largely eliminated
5-HT effects (interneuron: 7.662.3%, n=4; pyramidal neuron:
211.263.6%, n=4). These data suggested that the enhancing effect
of 5-HT in FS interneurons is predominantly mediated by 5-HT2
receptors, while the reducing effect of 5-HT in pyramidal neurons is
mainly mediated by 5-HT1 receptors.
The effect of in vitro or in vivo fluoxetine administration
on the excitability of FS interneurons and pyramidal
neurons in PFC
Fluoxetine, a selective serotonin reuptake inhibitor, is the most
widely used antidepressant drug [36]. Next, we examined whether
endogenous activation of 5-HT receptors by fluoxetine could also
alter the excitability of PFC neurons. As shown in Fig. 3A, bath
application of fluoxetine (10 mM) significantly increased the firing
rate of FS interneurons, but had little effect on pyramidal neurons.
A higher dose of fluoxetine (100 mM) gave similar enhancement
in FS interneurons (Fig. 3B, 10 mM: 32.762.3%, 100 mM:
39.264.8%, n=5), and only slightly decreased the firing rate of
pyramidal neurons (Fig. 3B, 10 mM: 23.361.4%, 100 mM:
216.562.2%, n=5–6). These data suggest that FS interneurons
are more sensitive to the in vitro application of fluoxetine.
Since the therapeutic effects of fluoxetine are not attained in
patients until 2–3 weeks after the beginning of treatment [37], the
Figure 1. The effect of 5-HT on AP firing in FS interneurons and pyramidal neurons of PFC. A, Representative AP recordings showing the
effect of 5-HT (20 mM) in a FS interneuron and a pyramidal neuron. Scale bars: 20 mV, 50 ms. B, Cumulative data (mean 6 SEM) showing the
percentage change of the firing rate by different doses of 5-HT in FS interneurons and pyramidal neurons.
doi:10.1371/journal.pone.0016970.g001
Effects of 5-HT in Different PFC Neurons
PLoS ONE | www.plosone.org 2 February 2011 | Volume 6 | Issue 2 | e16970Figure 2. Different 5-HT receptors mediate the effect of 5-HT on AP firing in PFC FS interneurons and pyramidal neurons. A, C,
Representative AP recordings showing the effect of 5-HT (20 mM) in the presence of the 5-HT2 antagonist Ketanserin (10 mM) or the 5-HT1 antagonist
NAN190 (10 mM) in a FS interneuron and a pyramidal neuron. Scale bars: 20 mV, 50 ms. B, D, Cumulative data (mean 6 SEM) showing the percentage
changes of the firing rate by 5-HT (20 mM) in the presence of different antagonists in FS interneurons and pyramidal neurons.
doi:10.1371/journal.pone.0016970.g002
Figure 3. The effect of in vitro fluoxetine application on AP firing in FS interneurons and pyramidal neurons of PFC. A, Representative
AP recordings showing that effect of bath application of fluoxetine (10 mM) in a FS interneuron and a pyramidal neuron. Scale bars: 20 mV, 50 ms. B,
Cumulative data (mean 6 SEM) showing the percentage change of the firing rate by different doses of fluoxetine in FS interneurons and pyramidal
neurons.
doi:10.1371/journal.pone.0016970.g003
Effects of 5-HT in Different PFC Neurons
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an effective way for chronic antidepressant testing [38,39]. This
regimen can cause behavioral, biochemical and physiological
changes that are associated with anti-depression efficacy of
fluoxetine [40,41]. So we injected rats with fluoxetine (10 mg/
kg/day) for 21 days to examine the impact of long-term fluoxetine
treatment on the excitability of PFC neurons. Saline injections
were used a control. As shown in Fig. 4, the intrinsic excitability, as
measured by the number of spikes elicited by injected depolarizing
current pulses (120–240 pA, 500 ms), was significantly increased
in PFC FS interneurons from fluoxetine-injected rats (160 pA:
Saline: 7.563, Fluox: 2464.5; 180 pA: Saline: 1764, Fluox:
32.566; 200 pA: Saline: 23.564.5, Fluox: 37.564.5, n=5 for
each group), while the excitability of PFC pyramidal neurons was
unchanged by fluoxetine injection (120 pA: Saline: 5.660.9,
Fluox: 5.160.7; 160 pA: Saline: 7.160.52, Fluox: 7.560.7;
200 pA: Saline: 9.260.7, Fluox: 9.360.4, n=6 for each group).
These results suggest that long-term fluoxetine treatment mainly
increased the excitability of FS interneurons, which could lead to
the enhanced inhibitory circuit in PFC.
The effect of serotonin on the excitability of PFC neurons
in animals with long-term fluoxetine treatment
Next, we examined whether exogenous application of 5-HT had
any effect on PFC in the rats with 20-day fluoxetine injection. As
shown in Fig. 5, the enhancing effect of 5-HT (2 mM) on FS
interneuron APs was significantly attenuated in fluoxetine-injected
rats, compared to saline-injected rats (saline: 36.865.3%, n=6,
fluox: 14.364.2%, n=5, p,0.01, t test). In contrast, the reducing
effect of 5-HT (2 mM) on pyramidal neuron APs was not altered
Figure 4. The effect of long-term in vivo fluoxetine treatment on the excitability of FS interneurons and pyramidal neurons. A, B, Plot
of spike numbers (mean 6 SEM) in response to different current (500 ms) injections in PFC FS interneurons and pyramidal neurons from rats i.p.
injected with saline or fluoxetine for 21 days. *: p,0.01, t test. C, D, Representative AP recordings in response to injected currents in FS interneurons
and pyramidal neurons from saline- or fluoxetine-injected rats. Scale bars: 20 mV, 50 ms.
doi:10.1371/journal.pone.0016970.g004
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suggests that chronic fluoxetine treatment significantly occluded
the effect of 5-HT in FS interneurons, while the excitability of
pyramidal neurons is regulated by 5-HT via a fluoxetine-
independent mechanism.
Discussion
In this study, we have revealed the effect of serotonin and
fluoxetine on the intrinsic excitability of PFC FS interneurons and
pyramidal neurons. Since action potential firing is the final output
of neurons, our results provide a framework for understanding the
role of serotonin and fluoxetine in regulating PFC network
activity, which is crucial for PFC-mediated cognitive processes
such as working memory [42]. It is known that FS interneurons
play a central role in determining the timing and spatial selectivity
of pyramidal firing [43], thus shaping the physiological outcome of
the PFC network. By increasing the excitability of PFC FS
interneurons, the feedforward inhibition could be enhanced by
serotonin and fluoxetine. The decreased excitability of PFC
pyramidal neurons in response to serotonin could further dampen
the circuit activity.
5-HT exerts complex effects on central neurons, depending on
the cell type, the channel target, the expression of 5-HT receptor
subtypes and the developmental stage [35,44,45]. 5-HT1A and 5-
HT2A receptors have been found in PFC pyramidal neurons and
interneurons [25], while it is unclear which receptor plays the
dominant role in these different types of neurons. Bath
administration of 5-HT produces two distinct responses in PFC
pyramidal neurons, the 5-HT1A-mediated membrane hyperpolar-
ization and the 5-HT2-mediated membrane depolarization [46].
Interestingly, the 5-HT-induced depolarization gradually shifts to
a hyperpolarization commencing during the third postnatal week
[45]. Electrical stimulation of the raphe nuclei elicits 5-HT1A-
mediated inhibition and 5-HT2A-mediated excitation in PFC
pyramidal neurons [47]. Moreover, 5-HT exerts a potent control
on slow and gamma oscillations in PFC through 5-HT1A and 5-
HT2A receptors, and induces distinct effects on the spiking of FS
interneurons in vivo [26]. In this study, we found that the 5-HT1A-
mediated decrease of intrinsic excitability is the predominant effect
of 5-HT in PFC pyramidal neurons from young adult rats
(,4 wk), while the 5-HT2-mediated increase of intrinsic excitabil-
ity is the predominant effect of 5-HT in PFC FS interneurons.
Since blocking synaptic transmission did not alter the 5-HT
regulation of AP firing, the opposing effects of 5-HT1A and 5-HT2
on neuronal excitability could be attributable to their coupling to
distinct ion channels including various K
+,C a
2+, or cation
channels [48–51].
Fluoxetine is an antidepressant drug whose therapeutic effect is
considered to be through the inhibition of serotonin reuptake and
the enhancement of serotonergic neurotransmission [36,15].
Fluoxetine also has several other modulatory effects, such as
inhibition of G protein-coupled receptors, blockade of monoamine
oxidases and modulation of Ca
2+ channels [52–54]. The effect of
fluoxetine on PFC neuronal excitability has been largely unknown.
In this study, we found that acute in vitro application of fluoxetine
Figure 5. The effect of 5-HT on AP firing in PFC neurons from fluoxetine-treated rats. A, Representative AP recordings showing the effect
of 5-HT (2 mM) in a FS interneurons and a pyramidal neuron from saline- or fluoxetine-injected rats. Scale bars: 20 mV, 50 ms. B, Cumulative data
(mean 6 SEM) showing the percentage change of the firing rate by 5-HT (2 mM) in FS interneurons and pyramidal neurons from saline- or fluoxetine-
injected rats. *: p,0.01, t test.
doi:10.1371/journal.pone.0016970.g005
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FS interneurons rather than pyramidal neurons. The smaller effect
of fluoxetine on APs, compared to the effect of exogenously
applied 5-HT, could be due to the limited level of endogenous 5-
HT in PFC slices. However, chronic in vivo administration of
fluoxetine also selectively alters the excitability of FS interneurons,
confirming that FS interneurons are more sensitive to elevated
endogenous 5-HT levels. It awaits to be investigated what
determines the selective sensitivity to fluoxetine. Since the effect
of exogenous application of 5-HT is largely occluded in FS
interneurons from fluoxetine-treated animals, it suggests that 5-
HT and fluoxetine converge onto a common set of membrane
mechanisms to increase interneuron excitability.
Materials and Methods
Electrophysiology recording in slices
All experiments were carried out with the approval of State
University of New York at Buffalo Animal Care Committee. Brain
slices containing PFC from young adult male rats (,4 weeks old)
were prepared as described previously [55]. In brief, animals were
anesthetized by inhaling 2-bromo-2-chloro-1,1,1-trifluoroethane
(1 ml/100 g, Sigma St. Louis, MO) and decapitated; brains were
quickly removed, iced, and then blocked for slicing. The blocked
tissue was cut in 300–400 mm slices with a vibrating slicer (VT
1000 s, Leica, Nussloch, Germany) while bathed in a HEPES-
buffered salt solution (in mM: 140 sodium isethionate, 2 KCl, 4
MgCl2, 0.1 CaCl2, 23 glucose, 15 HEPES, 1 kynurenic acid,
pH 7.4, 300–305 mosM/liter). Slices were then incubated for 1–
5 hr at room temperature (20–22uC) in a NaHCO3-buffered saline
bubbled with 95% O2,5 %C O 2 (in mM): 126 NaCl, 2.5 KCl, 2
CaCl2, 2 MgCl2, 26 NaHCO3, 1.25 NaH2PO4, 10 glucose, 1
pyruvic acid, 0.05 glutathione, 0.1 N
G-nitro-L-arginine, 1
kynurenic acid, pH=7.4, 300–305 mosM. The slice was trans-
ferred to a perfusion chamber attached to the fixed-stage of an
upright microscope (Olympus) and submerged in continuously
flowing oxygenated artificial cerebrospinal fluid (ACSF). Neurons
were visualized with a 406water-immersion lens and illuminated
with near infrared (IR) light, and the image was detected with an
IR-sensitive CCD camera.
Whole-cell current-clamp recordings were performed using the
similar approach as we described before [56]. Patch electrodes
were filled with the internal solution (in mM): 60 K2SO4,6 0N-
methyl-D-glucamine, 40 HEPES, 4 MgCl2, 0.5 EGTA, 12
phosphocreatine, 3 Na2ATP, 0.5 Na3GTP, 20 leupeptin,
pH=7.2–7.3, 265–270 mosM. Recordings were obtained with a
DIGIDATA 1322A acquisition system and a Multiclamp 700A
amplifier controlled by a computer running pClamp (Axon
instruments, Foster City, CA). Action potentials were evoked by
somatic injections of current pulses. The resting membrane
potential was usually lower than 260 mV before being triggered
to fire APs by the depolarizing pulses. Quantitative measurements
were taken at 3–5 min after drug application. Numerical values
were expressed as mean 6 SEM. Statistical comparisons of drug
effects were made using the student t test or ANOVA.
Antidepressant treatment
Young male rats were administered intraperitoneally either with
the antidepressant fluoxetine (10 mg/kg) or saline for 21 days
(once daily) as we described before [31]. Experimental groups
were matched such as a fluoxetine-treated rat and saline-treated
control rat were sacrificed on the same day and tissues were
processed in parallel.
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